Context card
Manufacturer, provider, deployer: who is who when a medical device contains AI
Which AI Act role does a medical device manufacturer, a hospital or an importer take on?
The short answer
The device manufacturer under the MDR or IVDR is, as a rule, the provider of the AI system under the AI Act, because it places the device with the AI on the market under its own name. A hospital that uses the device is a deployer with its own duties; importers, distributors and authorised representatives have counterparts in both laws, but the duties differ and must be read in each law.
For: Regulatory affairs, technical writers and project managers working on AI-enabled medical devices
Key points
- MDCG 2025-6 reads MDR/IVDR references to the manufacturer as references to the provider for AI in devices.
- A user under the MDR is not automatically a deployer under the AI Act; the deployer is the organisation using the system under its authority.
- Deployers of high-risk AI systems have their own duties: use according to the instructions, human oversight by competent people, keeping logs, monitoring.
- Authorised representative, importer and distributor exist in both laws; each law sets its own duties.
- A hospital that builds and uses its own AI device can be manufacturer and provider at once (in-house devices, MDR Art. 5(5)).
The context
Two laws, one product
The MDR names its actors economic operators: manufacturer, authorised representative, importer, distributor. The AI Act names provider, deployer, authorised representative, importer and distributor. For AI in a device, the two sets meet in one product.
Manufacturer and provider
The provider is whoever develops an AI system, or has it developed, and places it on the market or puts it into service under its own name. For a device that contains an AI system, that is the device manufacturer. MDCG 2025-6 says that references to the manufacturer in the MDR and IVDR are to be understood as references to the provider in the AI Act for this purpose. The documentation consequence: one organisation answers for one file (see the crosswalk card).
User and deployer
The MDR "user" is the person who uses the device — a clinician, a nurse, a patient. The AI Act deployer is the natural or legal person using the AI system under its authority in a professional activity — typically the hospital or the practice, not each clinician. Deployers of high-risk AI systems use them according to the instructions for use, assign human oversight to competent people, keep the logs under their control and inform the provider about risks and serious incidents (Article 26).
For the technical writer this means: the IFU now has two kinds of readers with duties — the clinical user and the organisation that deploys the system.
Representative, importer, distributor
All three exist in both laws, with their own duties. A non-EU manufacturer needs an authorised representative under the MDR and, for a high-risk AI system, under the AI Act; one organisation can hold both mandates, but each mandate must be written down.
Special cases
- In-house devices: a health institution that makes and uses a device in-house under the conditions of MDR Article 5(5) and develops the AI itself can be provider and deployer at once. MDCG 2025-6 announces further guidance on in-house AI.
- Changing the purpose: whoever changes the intended purpose of a high-risk AI system or modifies it substantially can become its provider (Article 25).
What this card does not say
It does not assign roles for a specific product or contract. Roles follow from facts — who places the product on the market, who uses it under its authority — and must be checked in both laws.
Questions readers ask next
- Is a hospital that uses an AI device the provider?
- No, as a rule it is the deployer. It becomes provider only if it places the system on the market under its own name, changes its intended purpose or modifies it substantially, or develops it itself.
- Is the clinician the deployer?
- Usually not. The deployer is the organisation using the system under its authority; clinicians are the users who exercise human oversight on its behalf.
- Can one authorised representative cover both laws?
- Yes, one organisation can hold both mandates, but each law requires its own written mandate with its own tasks.
Sources
- Regulation (EU) 2024/1689 (Artificial Intelligence Act) — EUR-Lex, 12 July 2024Law in force: Binding legislation that applies as of the review date.
- Regulation (EU) 2017/745 on medical devices (MDR) — EUR-Lex, 5 May 2017Law in force: Binding legislation that applies as of the review date.
- MDCG 2025-6 / AIB 2025-1: FAQ on the interplay between the MDR/IVDR and the AI Act — Medical Device Coordination Group and Artificial Intelligence Board, 19 June 2025Final guidance: Guidance published in its final form by an authority or an official body. Guidance explains the law; it is not law itself.
Review log and changes
Every context card is checked against its sources before it is published, and again whenever it changes; the date under the byline is the last review. Corrections (something was wrong) and additions (something was missing) are logged below with date and time (Berlin time). Typos, formatting and link fixes are not listed.
Reviewed
No corrections or additions since publication.